185 related articles for article (PubMed ID: 34315659)
21. Pattern and determinants of diagnostic interval in cancers of the prostate, bladder and kidney.
Talamini R; Franceschi S; Dal Bo V; Monfardini S
Tumori; 1991 Aug; 77(4):350-4. PubMed ID: 1746059
[TBL] [Abstract][Full Text] [Related]
22. Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.
Urquidi V; Rosser CJ; Goodison S
Curr Med Chem; 2012; 19(22):3653-63. PubMed ID: 22680923
[TBL] [Abstract][Full Text] [Related]
23. From Leonardo to da Vinci: the history of robot-assisted surgery in urology.
Yates DR; Vaessen C; Roupret M
BJU Int; 2011 Dec; 108(11):1708-13; discussion 1714. PubMed ID: 21951677
[TBL] [Abstract][Full Text] [Related]
24. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880
[TBL] [Abstract][Full Text] [Related]
25. Proteomic studies in urological malignancies.
Ferguson RE; Selby PJ; Banks RE
Contrib Nephrol; 2004; 141():257-79. PubMed ID: 14650238
[No Abstract] [Full Text] [Related]
26. [Positron emission tomography (PET) and PET-CT in renal, bladder and prostate cancer: update].
Delgado Bolton RC; Mucientes Rasilla J; Pérez Castejón MJ; Carreras Delgado JL
Actas Urol Esp; 2009 Jan; 33(1):11-23. PubMed ID: 19462720
[TBL] [Abstract][Full Text] [Related]
27. Yinghao Sun: leader of research on prostate cancer in China.
Alcorn T
Lancet; 2015 Jan; 385(9965):321. PubMed ID: 25706842
[No Abstract] [Full Text] [Related]
28. Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
Seltz LM; Herrell SD
Curr Opin Urol; 2016 May; 26(3):259-63. PubMed ID: 26914060
[TBL] [Abstract][Full Text] [Related]
29. [Update urooncology: news with clinical relevance from major scientific meetings 2012].
Hegele A; Skrobek L; Schrader AJ
Aktuelle Urol; 2012 Dec; 43(6):376-87. PubMed ID: 23254351
[TBL] [Abstract][Full Text] [Related]
30. [News with clinical relevance from major scientific meetings 2014 - Update Urooncology].
Hegele A; Skrobek L; Boegemann M
Aktuelle Urol; 2015 Mar; 46(2):106-17. PubMed ID: 25909966
[TBL] [Abstract][Full Text] [Related]
31. [From "Karzinos" to modern urologic oncology : A long way from the first surgical procedures to targeted therapy].
Konert J
Urologe A; 2016 Aug; 55(8):1102-8. PubMed ID: 27422312
[TBL] [Abstract][Full Text] [Related]
32. [Indications and limitations of ultrasound and axial computed tomography in urologic oncology].
Braeckman J; Denis L; Appel B; Van Erps P
Acta Urol Belg; 1985; 53(3):514-9. PubMed ID: 3904357
[No Abstract] [Full Text] [Related]
33. [New therapies for urologic cancer diseases. The Danish Society of Urology].
Lund L; Borre M; Hermann GG; Svolgaard N;
Ugeskr Laeger; 2008 Mar; 170(12):1057. PubMed ID: 18397675
[No Abstract] [Full Text] [Related]
34. Theranostic and prognostic biomarkers: genomic applications in urological malignancies.
Netto GJ; Epstein JI
Pathology; 2010 Jun; 42(4):384-94. PubMed ID: 20438413
[TBL] [Abstract][Full Text] [Related]
35. Urological tumours: recent changes.
Gardiner RA
Aust N Z J Surg; 1995 May; 65(5):350-8. PubMed ID: 7537956
[TBL] [Abstract][Full Text] [Related]
36. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
Netto GJ
Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of current developments in genitourinary pathology.
Zhou AG; Owens CL; Cosar EF; Jiang Z
Arch Pathol Lab Med; 2013 Jul; 137(7):887-93. PubMed ID: 23808460
[TBL] [Abstract][Full Text] [Related]
38. [RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience].
Trouche-Sabatier SG; Rebillard X; Iborra F; Azria D; Daures JP; Poinas G; Abdo N; Delbos O; Gevorgyan A; Marchal S; Guillon R; Millet I; Lamy PJ; Lauche O; Reis-Borges R; Serre I; Topart D; Tretarre B;
Prog Urol; 2020 Dec; 30(16):1038-1044. PubMed ID: 33012630
[TBL] [Abstract][Full Text] [Related]
39. The role of imaging in the surveillance of urologic malignancies.
Bradford TJ; Montie JE; Hafez KS
Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
